Clinical Trial Update: Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia

View source ↗

Summary

Clinical trial update describing the clinical and demographic features of patients with moderate-to-severe active systemic lupus erythematosus studied in Russia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED